Announcing a new article publication for Cardiovascular Innovations and Applications journal.
Traditional percutaneous coronary intervention (T-PCI) has long been an effective method for treating coronary heart disease (CHD), but the radiation hazards and orthopedic injuries among T-PCI operators are concerning.
These problems have been mitigated with the emergence of robotic percutaneous coronary intervention (R-PCI), which is expected to increase intervention accuracy and safety. In this review, the current status of PCI development is summarized, including robot systems, and PCI application and evaluation. T-PCI and R-PCI are compared to identify the benefits for patients and physicians. In addition, a new R-PCI system is described, R-PCI WSER-CD01, which incorporates multi-instrument collaborative delivery and provides full-process assistance in minimally invasive vascular intervention.
This system introduces three key innovations that address safety concerns, and improve the accuracy, wire compatibility, and remote operation capabilities of existing of vascular intervention robot systems. Finally, prospects for the development of R-PCI are discussed. As an emerging technology, R-PCI aligns well with the trends of precision medicine and telemedicine, and therefore warrants continued innovation.
Source:
Journal reference:
Song, Y-J., et al. (2023) Robotic Percutaneous Coronary Intervention in Coronary Heart Disease: Applications and Recent Advances. Cardiovascular Innovations and Applications. doi.org/10.15212/CVIA.2023.0062.